Healthcare -
Biotechnology - NASDAQ - US
$ 1.98
-1.01 %
$ 147 M
Market Cap
-3.38
P/E
IKT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities IKT - Inhibikase Therapeutics, Inc.
103 M
LAST VALUE
2152.42%
2 YEAR CAGR
438.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR